Método de evaluación del proceso de enseñanza aprendizaje utilizados por los docentes en la Facultad de Educación de la Universidad Nacional de San Martín

El presente estudio sobre los métodos de evaluación del proceso de enseñanza aprendizaje utilizados por los docentes en la Facultad de Educación de la Universidad Nacional de San Martín, Pretende demostrar que los docentes de esta universidad recurren a diverso métodos de evaluación de los aprendizajes en su labor docente , pero la diversidad de las especialidades hace también que por la naturaleza de ellas cada docente busque su propia metodología de evaluación lo cual no uniformiza la recolección de datos mediante los instrumentos de evaluación que él mismo diseña o recurren a la elaboración de cuestionarios pero sin criterios pedagógicos, se concluye que muchos de los docentes requieren de ser capacitados en evaluación tanto en el aspecto conceptual como el instrumental, y así podrán tener una mejor dirección del aprendizaje en sus respectivas cátedrasUniversidad Nacional de Educación Enrique Guzmán y Valle.Tesi

The effects of reprocessing and fiber treatments on the properties of polypropylene-sugarcane bagasse biocomposites

This study explores the reprocessing behavior of polypropylene-sugarcane bagasse biocomposites using neat and chemically treated bagasse fibers (20 wt.%). iocomposites were reprocessed 5 times using the extrusion process followed by injection molding. The mechanical properties indicate that microfibers bagasse fibers addition and chemical treatments generate improvements in the mechanical properties, reaching the highest performance in the third cycle where the flexural modulus and flexural strength increase 57 and 12% in comparison with neat PP. differential scanning calorimetry (DSC) and TGA characterization show that bagasse fibers addition increases the crystallization temperature and thermal stability of the biocomposites 7 and 39 °C respectively, without disturbing the melting process of the PP phase for all extrusion cycles. The rheological test shows that viscosity values of PP and biocomposites decrease progressively with extrusion cycles; however, Cole–Cole plots, dynamic mechanical analysis (DMA), width at half maximum of tan delta peaks and SEM micrographs show that chemical treatments and reprocessing could improve fiber dispersion and fiber–matrix interaction. Based on these results, it can be concluded that recycling potential of polypropylene-sugarcane bagasse biocomposites is huge due to their mechanical, thermal and rheological performance resulting in advantages in terms of sustainability and life cycle impact of these material

Effect of extrusion screw speed and plasticizer proportions on the rheological, thermal, mechanical, morphological and superficial properties of PLA

One of the critical processing parameters—the speed of the extrusion process for plasticized poly (lactic acid) (PLA)—was investigated in the presence of acetyl tributyl citrate (ATBC) as plasticizer. The mixtures were obtained by varying the content of plasticizer (ATBC, 10–30% by weight), using a twin screw extruder as a processing medium for which a temperature profile with peak was established that ended at 160 °C, two mixing zones and different screw rotation speeds (60 and 150 rpm). To evaluate the thermo-mechanical properties of the blend and hydrophilicity, the miscibility of the plasticizing and PLA matrix, Fourier transform infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC), oscillatory rheological analysis, Dynamic Mechanical Analysis (DMA), mechanical analysis, as well as the contact angle were tested. The results derived from the oscillatory rheological analysis had a viscous behavior in the PLA samples with the presence of ATBC; the lower process speed promotes the transitions from viscous to elastic as well as higher values of loss modulus, storage modulus and complex viscosity, which means less loss of molecular weight and lower residual energy in the transition from the viscous state to the elastic state. The mechanical and thermal performance was optimized considering a greater capacity in the energy absorption and integration of the components

Injection molding of coir coconut fiber reinforced polyolefin blends: mechanical, viscoelastic, thermal behavior and three-dimensional microscopy Study

In this study, the properties of a polyolefin blend matrix (PP-HDPE) were evaluated and modified through the addition of raw coir coconut fibers-(CCF). PP-HDPE-CCF biocomposites were prepared using melt blending processes with CCF loadings up to 30% (w/w). CCF addition generates an increase of the tensile and flexural modulus up to 78% and 99% compared to PP HDPE blend. This stiffening effect is caused by a decrease in the polymeric chain mobility due to CCF, the higher mechanical properties of the CCF compared to the polymeric matrix and could be an advantage for some biocomposites applications. Thermal characterizations show that CCF incorporation increases the PP-HDPE thermal stability up to 63 ◦C, slightly affecting the melting behavior of the PP and HDPE matrix. DMA analysis shows that CCF improves the PP-HDPE blend capacity to absorb higher external loads while exhibiting elastic behavior maintaining its characteristics at higher temperatures. Also, the three-dimensional microscopy study showed that CCF particles enhance the dimensional stability of the PP-HDPE matrix and decrease manufacturing defects as shrinkagein injected specimens. This research opens a feasible opportunity for considering PP-HDPE-CCF biocomposites as alternative materials for the design and manufacturing of sustainable products by injection moldin

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p&lt;0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (&lt;1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (&lt;1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≥ II, EF ≤35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure &lt; 100 mmHg (n = 1127), estimated glomerular filtration rate &lt; 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation

Manufacturing rigid board by packaging waste containing aluminum and polyethylene

Este estudio presenta la viabilidad de usar polietileno de baja densidad (LDPE) reciclado y aluminio de Tetra Pak para fabricar tableros rígidos compuestos utilizando una prensa en caliente. Los compuestos de LDPE / Al se vieron afectados significativamente por el efecto de la presión de compactación durante el procesamiento, especialmente en la resistencia a la tracción y la absorción de agua. El compuesto presenta una baja absorción de agua y una resistencia a la tracción aceptable.This study presents feasibility of using recycled low density polyethylene (LDPE) and aluminum of Tetra Pak to manufacture composite rigid board using a hot press. Compounds of LDPE / Al were significantly affected by the effect of compaction pressure during processing, especially in tensile strength and water absorption. Composite presents low water absorption, and acceptable tensile strengt

Método de evaluación del proceso de enseñanza aprendizaje utilizados por los docentes en la Facultad de Educación de la Universidad Nacional de San Martín

Universidad Nacional de Educación Enrique Guzmán y Valle.TesisEl presente estudio sobre los métodos de evaluación del proceso de enseñanza aprendizaje utilizados por los docentes en la Facultad de Educación de la Universidad Nacional de San Martín, Pretende demostrar que los docentes de esta universidad recurren a diverso métodos de evaluación de los aprendizajes en su labor docente , pero la diversidad de las especialidades hace también que por la naturaleza de ellas cada docente busque su propia metodología de evaluación lo cual no uniformiza la recolección de datos mediante los instrumentos de evaluación que él mismo diseña o recurren a la elaboración de cuestionarios pero sin criterios pedagógicos, se concluye que muchos de los docentes requieren de ser capacitados en evaluación tanto en el aspecto conceptual como el instrumental, y así podrán tener una mejor dirección del aprendizaje en sus respectivas cátedra